Fluoromethylketone‐Fragment Conjugates Designed as Covalent Modifiers of Ec DsbA are Atypical Substrates

Documenti analoghi

• How to Find a Fragment: Methods for Screening and Validation in Fragment‐Based Drug Discovery
  di: Tim Kirkman, et al.
  Pubblicazione: (2024)
• Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV‐CA Binding Fragments
  di: Stuart Lang, et al.
  Pubblicazione: (2024)
• Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors
  di: Ehab S. Taher, et al.
  Pubblicazione: (2024)
• Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors
  di: Gints Kalnins, et al.
  Pubblicazione: (2024)
• Front Cover: Fragment‐Based Design, Synthesis, and Characterization of Aminoisoindole‐Derived Furin Inhibitors (ChemMedChem 9/2024)
  di: Roman W. Lange, et al.
  Pubblicazione: (2024)